InvestorsHub Logo
Followers 29
Posts 3799
Boards Moderated 0
Alias Born 12/28/2005

Re: None

Monday, 11/07/2022 4:23:31 PM

Monday, November 07, 2022 4:23:31 PM

Post# of 22710
I missed 2 things, after all this time. Looks like Venkat

Either worked for or brought another company public. Even if he
didn’t, he still had the companies revs grow 10x

Venkat comes with a very rich and global experience of successfully leading organizations in the Life sciences and Consumer Products businesses. He has held top management roles in the life sciences space in companies like Shantha Biotech (A Sanofi Company) and Aurobindo Pharma and he immensely contributed to their all-round growth. Shantha Biotech- a biosimilar and vaccine company, was eventually acquired by Sanofi for around $ 800 MN in 2010. He has been a part of significant revenue growth and significant value creation in Aurobindo Pharma in the global business segment of APIs and finished dosage form products in multiple therapy areas.
He has held CEO roles in Emami and Cavinkare, CPG companies, growing them significantly with an all rounded approach. During his stint at Emami (a listed company) as CEO, the company's market cap went up from $ 300 MN to $ 1.2 BN. The momentum thus created, has made Emami a $ 3.7 BN market cap company now.

During early part of his career, he created some very successful brands in Cavinkare, a leading CPG company from India, and built the organization with a 10X revenue increase in 6 years’ time and that early momentum has made Cavinkare one of the established Consumer product companies in India. He comes with core strengths in Strategy, Innovation, Marketing, Organization building, Finance, M&A and
Governance. He has been an integral part of many industrial forums in Life sciences and CPG business.

I’m sure someone posted this buts it’s a good reminder of what he has and can do here,

Ts